PlainRecalls
FDA Devices Moderate Class II Ongoing

ARCHITECT Anti-HCV Reagent Kit, List Numbers: a) 1L79-25, b) 1L79-35

Reported: April 10, 2024 Initiated: March 4, 2024 #Z-1479-2024

Product Description

ARCHITECT Anti-HCV Reagent Kit, List Numbers: a) 1L79-25, b) 1L79-35

Reason for Recall

Customer complaints were received regarding falsely elevated results for some patient samples. Internal studies with customer return samples confirmed potential interactions that may lead to falsely elevated results when processed as below on the same instrument: " ARCHITECT Syphilis TP (LN 8D06) and/or ARCHITECT AdviseDx SARS-CoV-2-IgG II (LN 6S60) precedes ARCHITECT Anti-HCV testing (LN 1L79). " Alinity i Syphilis TP (LN 07P60) precedes Alinity i Anti-HCV testing (LN 08P05).

Details

Recalling Firm
Abbott GmbH
Units Affected
7219 units
Distribution
US Nationwide distribution.
Location
Wiesbaden

Frequently Asked Questions

What product was recalled?
ARCHITECT Anti-HCV Reagent Kit, List Numbers: a) 1L79-25, b) 1L79-35. Recalled by Abbott GmbH. Units affected: 7219 units.
Why was this product recalled?
Customer complaints were received regarding falsely elevated results for some patient samples. Internal studies with customer return samples confirmed potential interactions that may lead to falsely elevated results when processed as below on the same instrument: " ARCHITECT Syphilis TP (LN 8D06) and/or ARCHITECT AdviseDx SARS-CoV-2-IgG II (LN 6S60) precedes ARCHITECT Anti-HCV testing (LN 1L79). " Alinity i Syphilis TP (LN 07P60) precedes Alinity i Anti-HCV testing (LN 08P05).
Which agency issued this recall?
This recall was issued by the FDA Devices on April 10, 2024. Severity: Moderate. Recall number: Z-1479-2024.